Celltrion Healthcare Reports 83% Decrease in Q3 Operating Profit to 22 Billion Won

[Asia Economy Reporter Jeong Dong-hoon]Celltrion Healthcare recorded an operating profit of 22 billion KRW in the third quarter of this year. This figure represents a decrease of 82.8% compared to the same period last year. During the same period, sales amounted to 409.1 billion KRW, down 11.7%, and net profit was 40.6 billion KRW, a decrease of 52.8%.

Celltrion Healthcare explained that sales declined due to adjustments in the supply volume and price of the anticancer biosimilar (biopharmaceutical generic) 'Truxima' in the United States, and profitability decreased due to a rise in cost ratio following the price adjustment of Truxima.

As of the third quarter, Celltrion Healthcare's cumulative sales totaled 1.1987 trillion KRW, operating profit was 129.7 billion KRW, and net profit was 135.8 billion KRW.

This content was produced with the assistance of AI translation services.